3/3/25 18:30 | 3/3/25 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Chiniara Ellen | MA | O | GC | S.d | -68 | 30.45 | 0 | -2 | -3 | 80 | D | | | | | | | | | | | | | | |
1/6/25 17:00 | 1/6/25 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Chiniara Ellen | MA | O | GC | S | -131 | 41.75 | 0 | -3 | -5 | 55 | D | | | | | | | | | | | | | | |
1/5/24 17:15 | 1/4/24 | KYMR | Kymera Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Chiniara Ellen | MA | O | GC | S | -74 | 22.58 | 0 | -3 | -9 | 34 | D | | | | | | | | | | | | | | |
9/5/17 19:43 | 8/31/17 | ALR | Alere Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Chiniara Ellen | MA | O | GC,Chief | M.d | 0 | 0.00 | 0 | 7 | 26 | 33 | D | | | | | | | | | | | | | | |
2/21/17 18:08 | 2/16/17 | ALR | Alere Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Chiniara Ellen | MA | O | GC,Chief | M.d | 0 | 0.00 | 23 | 10 | 53 | 28 | D | -8 | -25 | 0 | 5 | 2 | 8 | 4 | -1 | 0 | -1 | -4 | | | |
10/18/16 17:40 | 10/14/16 | ALR | Alere Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Chiniara Ellen | MA | O | GC,Chief | M.d | 944 | 37.74 | 21 | 25 | | 22 | D | 17 | -10 | -14 | -2 | 6 | -2 | -3 | -1 | 2 | 6 | -15 | -5 | 15 | |
9/13/16 17:23 | 9/9/16 | ALR | Alere Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Chiniara Ellen | MA | O | GC,Chief | M.d | 0 | 0.00 | 33 | 7 | 76 | 15 | D | 17 | -18 | -20 | 1 | 16 | 7 | 10 | 2 | 0 | 2 | 0 | -12 | -14 | |
9/2/15 16:53 | 8/31/15 | ALR | Alere Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Chiniara Ellen | MA | O | GC,Chief | M.d | 0 | 0.00 | 33 | 7 | 359 | 9 | D | 64 | 41 | 11 | -2 | -2 | -5 | -4 | -3 | 0 | 1 | -4 | -20 | 4 | -25 |